| ACUPA | ((S)-2-(3-((S)-5-amino-1- carboxypentyl) ureido) pentanedioic acid |
| BNCT | boron neutron capture therapy |
| BSB | binding site barrier |
| Chk | choline kinase |
| DFB | deferoxamine B |
| DUPA | 2-[3-(1,3-dicarboxypropyl)-ureido]pentanedioic acid |
| EPR | enhanced permeability and retention |
| FDA | Food and Drug Administration |
| GCPII | glutamate carboxypeptidase II |
| GRPR | gastrin-releasing peptide receptors |
| NPs | nanoparticles |
| PCa | prostate cancer |
| PEI | polyethyleneimine |
| PEG | polyethylene glycol |
| PET | positron emission tomography |
| PLA | polylactic acid |
| PLGA | poly(D,L-lactide-co-glycolide) |
| PSMA | prostate specific membrane antigen |
| SPECT | single-photon emission computerized tomography |
| TFA | trifluoroacetic acid |